Am Heart J

1. AGHARAHMANIAN A, Min KH, Go AS, Parikh RV, et al
   Incidence, medical therapy, and outcomes in heart failure with improved ejection fraction across guideline definitions.
   Am Heart J. 2026 Sep 6:107595. doi: 10.1016/j.ahj.2026.107595.
   

   >> Share

   
   
2. NARI JM, Siu S, D'Souza R, Pfaller B, et al
   Pregnancy outcomes in women with a history of myocarditis.
   Am Heart J. 2026;302:107547.
   

   >> Share

   
   

   
   Am J Cardiol

3. DODIN B, Sodhi P, Konz M, Hess T, et al
   Risk Factors Associated with Decompensated Heart Failure Following Successful Cardioversion of Atrial Fibrillation and Atrial Flutter: A Validation Cohort.
   Am J Cardiol. 2026 Sep 11:S0002-9149(26)00572.
   

   >> Share

   
   
4. BOCCHINO PP, Carbonaro C, Gallone G, Galli G, et al
   Non-Invasive Hemodynamic And Echocardiographic Changes Following Vericiguat Initiation In Heart Failure With Reduced Ejection Fraction: A Prospective Registry Study.
   Am J Cardiol. 2026 Sep 6:S0002-9149(26)00552.
   

   >> Share

   
   
5. VASQUEZ ARIZA S, Pedrosa DEDT, Diaz PO Jr, Jumkhawala S, et al
   Impact of Chronic Kidney Disease Stage on In-Hospital Bleeding and Mortality in Percutaneous Left Ventricular Assist Device Recipients: A Nationwide Perspective.
   Am J Cardiol. 2026;276:86-92.
   

   >> Share

   
   
6. GREYDANUS M, Dimitri DS, Khan OA, Khan KR, et al
   Diagnosis, Referral, Treatment Delays, and Outcomes in Veterans Affairs Patients Undergoing TAVR.
   Am J Cardiol. 2026;276:54-57.
   

   >> Share

   
   

   
   Cardiovasc Res

7. SHUMLIAKIVSKA M, Hemmerling I, Cremer S, Kirschbaum K, et al
   DNMT3A-driven clonal haematopoiesis induces semaphorin 4A-dependent endothelial activation in heart failure.
   Cardiovasc Res. 2026 Sep 5:cvag192. doi: 10.1093.
   

   >> Share

   
   

   
   Circ Heart Fail

8. LIN S, Wang Q, Cao J
   Heart Failure and Neurocognitive Disorders: A Narrative Review.
   Circ Heart Fail. 2026 Sep 11:e014265. doi: 10.1161/CIRCHEARTFAILURE.126.014265.
   

   >> Share

   
   
9. QIAN Z, Lee HC, Mulpuru SK, Vuckovic I, et al
   Cardiac Resynchronization Therapy and Circulating Metabolomic Profile in Patients With Advanced Heart Failure.
   Circ Heart Fail. 2026 Sep 10:e014148. doi: 10.1161/CIRCHEARTFAILURE.125.014148.
   

   >> Share

   
   

   
   Circ Res

10. LINKE WA, Kumper L, Fomin A, Martin I, et al
    Nx3 Is a Z-Disk Structural and Signaling Hub That Is Reduced in Heart Failure.
    Circ Res. 2026 Sep 10. doi: 10.1161/CIRCRESAHA.125.327786.
    

    >> Share

    
    
11. ZHOU C, Fu L, Yuan T, Li F, et al
    Mast Cell St8sia1 Is a Glyco-Epigenetic Checkpoint Driving Cardiac Remodeling.
    Circ Res. 2026;139:e328171.
    

    >> Share

    
    

    
    Circulation

12. PURI K, Allen K, Jentzer J, Soderstrom R, et al
    Surviving Pediatric Cardiogenic Shock: Clinical Approach, Improving Outcomes, and Future Directions: A Scientific Statement From the American Heart Association.
    Circulation. 2026;154:e374-e392.
    

    >> Share

    
    

    
    Clin Cardiol

13. POTOUPNI V, Boulmpou A, Maragkoudakis S, Briasoulis A, et al
    Prospective Evaluation of Quality-of-Life Improvement After Dapagliflozin Initiation in a Greek Population With HFrEF: The EVOLUTION-HF 12-Month Results.
    Clin Cardiol. 2026;49:e70466.
    

    >> Share

    
    

    
    Eur Heart J

14. FINOCCHIARO G, Perotto M, Merlo M, Luscher TF, et al
    Reconciling evidence-based and personalized medicine: perspectives in heart failure and cardiomyopathies.
    Eur Heart J. 2026 Sep 7:ehag596. doi: 10.1093.
    

    >> Share

    
    
15. CREA F
    Novel risk scores for the prediction of heart failure.
    Eur Heart J. 2026;47:4705-4710.
    

    >> Share

    
    
16. HARADA T, Reddy YNV, Sorimachi H, Naser JA, et al
    Exercise stress echocardiography for diagnosis of heart failure with preserved ejection fraction: a multicentre study.
    Eur Heart J. 2026 Sep 10:ehag716. doi: 10.1093.
    

    >> Share

    
    

    
    Eur J Heart Fail

17. SKAARUP KG, Lassen MCH, Yafasov M, Pareek M, et al
    RSV vaccine for preventing respiratory and cardiovascular hospitalizations in heart failure: a prespecified analysis of the extended DAN-RSV trial.
    Eur J Heart Fail. 2026 Sep 7:xuag282. doi: 10.1093.
    

    >> Share

    
    
18. OMODARA A, Assmus B, Witte KK, Straw S, et al
    Hierarchical composite endpoints in heart failure trials: clarity or confusion?
    Eur J Heart Fail. 2026 Sep 7:xuag263. doi: 10.1093.
    

    >> Share

    
    
19. CAMPBELL RT, Docherty KF, Lam CSP, Lowe DJ, et al
    Reply to: Comment on "Artificial Intelligence Fully Automated Analysis of Handheld Echocardiography in Real-World Patients with Suspected Heart Failure".
    Eur J Heart Fail. 2026 Sep 8:xuag287. doi: 10.1093.
    

    >> Share

    
    
20. ATTANASIO A, Disabato G, Guida G, Ambrogi F, et al
    Pharmacological optimisation in the treatment of Heart Failure in Women (PopS-HF): rationale and design of a prospective pragmatic, multicentre, randomised trial.
    Eur J Heart Fail. 2026 Sep 8:xuag293. doi: 10.1093.
    

    >> Share

    
    
21. CHIMURA M, Docherty KF, Henderson AD, Desai AS, et al
    Phenotype-specific prognostic implications of pulse pressure in heart failure.
    Eur J Heart Fail. 2026 Sep 11:xuag292. doi: 10.1093.
    

    >> Share

    
    

    
    Int J Cardiol

22. VALERO E, de la Espriella R, Minana G, Santas E, et al
    Carbohydrate antigen 125 for predicting right ventricular dysfunction and right ventricular to pulmonary artery uncoupling in acute heart failure: a cardiac magnetic resonance study.
    Int J Cardiol. 2026;464:134778.
    

    >> Share

    
    
23. HOBBACH AJ, Hochadel M, Angermann C, Stork S, et al
    PARADIGM-HF eligibility in historical German HFrEF populations: clinical characteristics and 1-year outcomes.
    Int J Cardiol. 2026;463:134749.
    

    >> Share

    
    

    
    J Am Coll Cardiol

24. WILSBACHER LD, Bucholz EM
    Genetic Variation in Hypoplastic Left Heart Syndrome Heart Failure Outcomes: A Layer of Risk to Stressed Myocardium.
    J Am Coll Cardiol. 2026;88:1154-1156.
    

    >> Share

    
    
25. BALINT BN, Sunthankar SD, Monaco G, Bair CA, et al
    Genetic Determinants of Early Heart Failure in Hypoplastic Left Heart Syndrome: A Prospective NC-DEFINE Study.
    J Am Coll Cardiol. 2026;88:1141-1153.
    

    >> Share

    
    

    
    J Card Fail

26. NARANG N, Cascino TM, Cowger JA, Kanwar MK, et al
    Variability in Status 1 Exception Practices and Candidate Outcomes After the 2018 US Heart Allocation Changes.
    J Card Fail. 2026;32:1501-1513.
    

    >> Share

    
    
27. JENNER WJ, Louca JO, Guajardo-Lozano JA, Hong SB, et al
    An International Comparative Analysis of Adult Donor Heart Allocation.
    J Card Fail. 2026;32:1485-1497.
    

    >> Share

    
    
28. UENO K, Kelley D, Shuto T, Miyamoto S, et al
    Stable Outcomes of Donation After Circulatory Death Heart Transplantation From Early Adoption to National Expansion.
    J Card Fail. 2026;32:1517-1525.
    

    >> Share

    
    
29. RIVAS-LASARTE M, Rodenas-Alesina E, Moayedi Y, Truby LK, et al
    Short-Term Mechanical Circulatory Support Before Heart Transplantation and Early Outcomes: Insights From the International Primary Graft Dysfunction Consortium.
    J Card Fail. 2026;32:1529-1539.
    

    >> Share

    
    
30. RAMU B, Shabbir A, Masotti M, Schultz J, et al
    Sex Differences in Simultaneous Heart-Kidney Transplantation: A 25-Year United Network for Organ Sharing Analysis.
    J Card Fail. 2026;32:1569-1580.
    

    >> Share

    
    
31. AHN DJ, Eap DK, Parker WF
    Beyond Categorical Tiers: Improving Measurement of Medical Urgency as the Foundation for Heart Allocation Reform.
    J Card Fail. 2026;32:1584-1593.
    

    >> Share

    
    
32. SAMSKY MD, Farr MA, Parikh AG, Moayedi Y, et al
    Beyond Tacrolimus: Toward Personalized Immunosuppression in Heart Transplantation.
    J Card Fail. 2026;32:1594-1604.
    

    >> Share

    
    
33. NATHAN A, Arabia F, Mahar J
    Extracorporeal Photopheresis in Heart Transplantation: From Salvage Therapy to Immunosuppression-Sparing Strategy.
    J Card Fail. 2026;32:1611-1621.
    

    >> Share

    
    
34. URIEL N, Clerkin K, Sayer G
    Heart Transplantation or LVAD First: Optimizing Life Prolongation in Young Patients with Advanced Heart Failure Pro Position: LVAD as Initial Strategy in Young Patients.
    J Card Fail. 2026;32:1629-1633.
    

    >> Share

    
    
35. MEHRA MR, Vukicevic M, Schoenrath F
    Heart Transplantation in 2076: Evolution, Transformation, or Obsolescence?
    J Card Fail. 2026;32:1647-1651.
    

    >> Share

    
    
36. VALANTINE H, Njoroge JN, Luikart H
    Heart Transplantation in 2076: From Scarcity to Cardiac Restoration.
    J Card Fail. 2026;32:1656-1659.
    

    >> Share

    
    
37. HEBDON MT, Breathett K
    Social Determinants of Health and Heart Failure Outcomes: Nuance and Complexity.
    J Card Fail. 2026 Sep 10:S1071-9164(26)00531.
    

    >> Share

    
    

    
    J Cardiol

38. HATANO R, Doi T, Kimura S, Furuoka R, et al
    Prognostic effect of liver fibrosis marker in systolic heart failure with cardiac nerve denervation and renal dysfunction.
    J Cardiol. 2026 Sep 7:S0914-5087(26)00179-6. doi: 10.1016/j.jjcc.2026.
    

    >> Share

    
    

    
    J Cardiovasc Pharmacol

39. LOTAN D, Elad B, Lee C, Richter I, et al
    The Novelty of Anticoagulation in LVAD Therapy: Current Practice, the Role of Direct Oral Anticoagulants, and Future Directions.
    J Cardiovasc Pharmacol. 2026;88:190-197.
    

    >> Share

    
    

    
    PLoS One

40. SALES MC, Zayat R, Hatam N, Berg T, et al
    Predicting the right! Validation of right heart failure predictive risk models after primary durable ventricular assist device implantation.
    PLoS One. 2026;21:e0357025.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share